Analysed VIVOS THERAPEUTICS INC (VVOS:NASDAQ) News Sources
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
05-06-2026
yahoo.com
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
08-06-2026
yahoo.com
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
10-06-2026
yahoo.com
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
11-06-2026
yahoo.com
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
22-06-2026
yahoo.com
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30-06-2026
yahoo.com
What is the current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is $0.4145.
VIVOS THERAPEUTICS INC (VVOS:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is $0.0016.
VIVOS THERAPEUTICS INC (VVOS:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is 0.3875%.
What is the most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The most recent sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is .
SEC-8K** Filing Available For VIVOS THERAPEUTICS INC (VVOS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.